Vasodilators and anesthesia induction agents may cause exaggerated hypotension in patients with LEMS-related autonomic dysfunction35
Because Lambert-Eaton myasthenic syndrome (LEMS) affects both the autonomic and neuromuscular systems, there are several specific treatment considerations to take into account when prescribing therapy for patients.
DRUG-DISEASE INTERACTIONSShareCopy LinkCOPIED!
Keep these potential drug-disease interactions in mind when recommending or prescribing medicines for conditions beyond LEMS
Beta-blockers and some antiarrhythmics (quinine, quinidine, procainamide) affect neuromuscular transmission and can exacerbate symptoms of muscle weakness in patients with LEMS36
Isolated reports of exacerbation of LEMS symptoms have been reported after administration of magnesium and intravenous iodinated radiographic contrast dyes36
Certain antibiotics, such as aminoglycosides, fluoroquinolones, and erythromycin, confer significant neuromuscular blocking effects and should be avoided in LEMS patients36-39
Anesthesia and LEMS
Avoid neuromuscular blocking agents (NMBAs) unless absolutely necessary; if necessary, use only small, titrated doses35
- LEMS patients are highly sensitive to both nondepolarizing and depolarizing NMBAs35,40
Patients undergoing surgery should continue LEMS treatment up until the time of surgery
- Respiratory insufficiency has been reported in patients taking neuromuscular blocking agents prior to surgery35
LEMS Aware is designed to be a resource for physicians to find the latest clinical data, news, and information regarding the diagnosis and treatment of patients with LEMS. Sign up for email alerts so that we can let you know as new content—such as teaching aids, webinars, and other useful resources—becomes available.